Concepedia

David R. Gandara

DR

33

Publications

1.9K

Citations

25

H-Index

1986

Active since

Affiliations

University of California, Davis(Current)

City Of Hope National Medical Center

University of Southern California

City of Hope

University of Chicago

David R. Gandara is an author at University of California, Davis specializing in medicine, oncology, and cancer therapeutics.

Top concepts

Publications per year

1986–2018

33

Publications

33

A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer

Ramesh K. Ramanathan, Chandra P. Belani, D. A. Singh et al. · Cancer Chemotherapy and Pharmacology · 2009 · 286 citations

, , +9

Trastuzumab plus docetaxel in HER‐2/<i>neu</i>‐positive prostate carcinoma

Primo N. Lara, Karen Giselle Chee, Jeff Longmate et al. · Cancer · 2004 · 114 citations

Trastuzumab plus Docetaxel in HER2/neu–Positive Non–Small-Cell Lung Cancer: A California Cancer Consortium Screening and Phase II Trial

Primo N. Lara, Luko Laptalo, Jeff Longmate et al. · Clinical Lung Cancer · 2004 · 108 citations

, , +6

GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis.

Paul J. Hesketh, William K. Murphy, Eric P. Lester et al. · Journal of Clinical Oncology · 1989 · 101 citations

, , +15

The Cyclin-Dependent Kinase Inhibitor UCN-01 Plus Cisplatin in Advanced Solid Tumors: A California Cancer Consortium Phase I Pharmacokinetic and Molecular Correlative Trial

Primo N. Lara, Philip C. Mack, Timothy W. Synold et al. · Clinical Cancer Research · 2005 · 96 citations

Rows per page

1–5 of 33